BioWorld by Clarivate Explores the New Era of Radiopharmaceuticals and its Emergence as a Novel Cancer Therapy

Special series investigates what the new uses and alternatives are and what the future of radiopharmaceutical therapy might look like LONDON, April 13, 2023 /PRNewswire/ — BioWorld™ published by Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.